Related Experiment Video
Updated: Oct 19, 2025

10:03
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Published on: July 5, 2019
9.0K
Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to
Arya Lekshmi Nair1,2, Lena Mesch3, Ingo Schulz4
1NMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.
Biosensors
|September 25, 2021
Summary
This study introduces a novel microfluidic platform for in vitro modeling of cellular barriers co-cultured with 3D tumor spheroids. The system enables real-time barrier tightness assessment using transepithelial/transendothelial electrical resistance (TEER) measurements.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Microfluidics
Background:
- Cellular barriers (endothelial and epithelial) are crucial for selective transport but are affected by inflammation and disease.
- In vitro modeling of cellular barriers aids in studying disease mechanisms and drug discovery.
- Current methods may lack the throughput or real-time monitoring capabilities for complex co-culture models.
Purpose of the Study:
- To develop a parallelizable microfluidic platform for co-culturing cellular barriers with 3D tumor spheroids.
- To integrate real-time barrier function monitoring into the microfluidic system.
- To demonstrate the platform's utility in studying tumor spheroid-cellular barrier interactions.
Main Methods:
- Fabrication of a microfluidic platform using microinjection molding, featuring ten independent cell culture chambers.
- Integration of electrodes for transepithelial/transendothelial electrical resistance (TEER) measurements using a FT-impedance system.
- Co-culture of HT29 tumor spheroids with MDCK cell barriers under continuous unidirectional flow.
Main Results:
- The microfluidic platform enabled parallelized, tubeless operation of ten distinct cultures.
- Real-time TEER measurements provided rapid assessment of cellular barrier integrity.
- Successful demonstration of HT29 tumor spheroid growth and interaction with MDCK cellular barriers.
Conclusions:
- The developed microfluidic platform offers a robust and efficient tool for in vitro modeling of cellular barriers and tumor spheroids.
- The integrated TEER measurement system allows for real-time monitoring of barrier function in complex co-culture models.
- This technology facilitates research into disease mechanisms, drug screening, and understanding tumor-host interactions.

